Alpha

Tau Unveils Groundbreaking Research in Logical Languages to Transform Software Development

Retrieved on: 
torsdag, april 11, 2024
Language, NSO, Software, Boolean, Research, Artificial intelligence, Follow, Mathematics, Logic, Algorithm, Alpha, Information technology

The recently published research paper by Ohad Asor, the founder and CTO of Tau, introduces significant advancements in the field of artificial intelligence (AI) with new logical languages, such as NSO and GSSOTC, designed to surpass currently widespread machine-learning methods by enabling formal proofs and reasoning over the entirety of any software developed using Tau Language.

Key Points: 
  • The recently published research paper by Ohad Asor, the founder and CTO of Tau, introduces significant advancements in the field of artificial intelligence (AI) with new logical languages, such as NSO and GSSOTC, designed to surpass currently widespread machine-learning methods by enabling formal proofs and reasoning over the entirety of any software developed using Tau Language.
  • The capabilities of Tau Language are indispensable for a wide range of AI-based software, from complex and mission-critical systems to simple applications.
  • The research covered in Theories and Applications of Boolean Algebras stands on four pillars:
    - NSO language, addressing the long-standing challenge of self-referential logic.
  • The publication of Theories and Applications of Boolean Algebras precedes the upcoming Tau Language Alpha release which will introduce core capabilities of the Tau Language.

HireRight Holdings Corporation investors: Please contact the Portnoy Law Firm to recover your losses; June 3, 2024 deadline

Retrieved on: 
fredag, maj 10, 2024
HireRight, Risk, Stifel, Employment, Growth, HRT, IPO, Defendant, Alpha, Security (finance)

LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises HireRight Holdings Corporation (“HireRight” or the “Company”) (NYSE: HRT) investors that a lawsuit was filed on behalf of investors that purchased HireRight securities pursuant and/or traceable to the Offering Documents issued in connection with HireRight’s October 2021 initial public offering (the “IPO” or “Offering”).

Key Points: 
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
  • On November 1, 2021, HireRight initiated its IPO, selling around 22 million shares of common stock at $19.00 per share.
  • Stifel also noted that a substantial portion of the company's growth stemmed from existing client hiring rather than new client acquisitions.
  • The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing.

Contact Hagens Berman by May 21, 2024 Deadline to Join Class Action Against Plug Power (PLUG)

Retrieved on: 
torsdag, maj 9, 2024
News, Morgan Stanley, Hydrogen, Growth, Plug Power, Hagens Berman, SAN, Person, Alpha

SAN FRANCISCO, May 09, 2024 (GLOBE NEWSWIRE) -- Hagens Berman, a prominent national trial attorney firm, is urging investors who suffered substantial losses in Plug Power Inc. (NASDAQ: PLUG) to take action by submitting your losses here .

Key Points: 
  • SAN FRANCISCO, May 09, 2024 (GLOBE NEWSWIRE) -- Hagens Berman, a prominent national trial attorney firm, is urging investors who suffered substantial losses in Plug Power Inc. (NASDAQ: PLUG) to take action by submitting your losses here .
  • Securities Fraud Class Action Against Plug Power Inc. (NASDAQ: PLUG): The lawsuit challenges Plug Power’s claims that its green hydrogen production plant construction was “on track” and that it had identified non-dilutive funding opportunities.
  • The complaint alleges that Plug Power made misleading statements and failed to disclose the following:
    Overstated Ability: Plug overstated its ability to mitigate the negative impacts of supply chain constraints and material shortages on its hydrogen business.
  • “We are investigating whether Plug may have deceived investors about the sufficiency of its liquidity,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Plug Power Inc. (PLUG)

Retrieved on: 
torsdag, maj 9, 2024
Probability, News, Suite, Hydrogen, GPM, Defendant, Court, Plug, GAAP, Alpha, Cryptocurrency

LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming May 21, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Plug Power Inc. (“Plug” or the “Company”) (NASDAQ: PLUG ) securities between March 1, 2023 and January 16, 2024, inclusive (the “Class Period”).

Key Points: 
  • LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming May 21, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Plug Power Inc. (“Plug” or the “Company”) (NASDAQ: PLUG ) securities between March 1, 2023 and January 16, 2024, inclusive (the “Class Period”).
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against HireRight Holdings Corporation (HRT)

Retrieved on: 
torsdag, maj 9, 2024
HireRight, News, Risk, Suite, Employment, GPM, HRT, IPO, Defendant, Court, Alpha, Security (finance)

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • On November 1, 2021, HireRight conducted its IPO, selling approximately 22 million shares of common stock at $19.00 per share.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HireRight, Checkpoint, Ocugen, and Sonder Innovations and Encourages Investors to Contact the Firm

Retrieved on: 
onsdag, maj 8, 2024
FDA, Radiation, Prospectus, CMO, Sonder, HireRight, News, Risk, Publication, Food, Annual report, Complaint, Hold, Employment, Biologics license application, HRT, Form, P.C, Risk management, IPO, Patient, Acquisition, CKPT, BLA, Register, Bank statement, CRL, Organization, Alpha, Security (finance)

Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.

Key Points: 
  • Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.
  • That same day, pursuant to the Offering Documents, HireRight’s common stock began publicly trading on the New York Stock Exchange (“NYSE”) under the ticker symbol HRT.
  • cites findings that arose during a multi-sponsor inspection of Checkpoint's third-party [CMO] as approvability issues to address in a resubmission."
  • For more information on the Sonder class action go to: https://bespc.com/cases/SOND

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Plug

Retrieved on: 
onsdag, maj 8, 2024
GAAP, LLP, Probability, News, Advertising, Economics, Morgan Stanley, FY, Complaint, Citigroup, Pressure, Court, Growth, Alpha, Cryptocurrency

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.

Key Points: 
  • Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.
  • The firm has recovered hundreds of millions of dollars for investors since its founding in 1995.
  • Faruqi & Faruqi, LLP also encourages anyone with information regarding Plug’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
  • The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ).

HireRight Holdings Corp. Stockholders Should Contact Robbins LLP Regarding the Pending Lead Plaintiff Deadline in the HRT Securities Class Action Lawsuit

Retrieved on: 
tisdag, maj 7, 2024
IPO, HireRight, News, Risk, Publication, Hold, Employment, HRT, Risk management, Organization, SAN, Alpha, Security (finance)

The Allegations: Robbins LLP is Investigating the Allegations that HireRight Holdings Corp. (HRT) Filed Misleading Documents in Connection with its IPO

Key Points: 
  • The Allegations: Robbins LLP is Investigating the Allegations that HireRight Holdings Corp. (HRT) Filed Misleading Documents in Connection with its IPO
    On November 1, 2021, HireRight began publicly trading on the NYSE under the ticker symbol HRT.
  • The complaint alleges that the Offering Documents in support of the IPO were negligently prepared.
  • What Now: You may be eligible to participate in the class action against HireRight Holdings Corp. Shareholders who want to serve as lead plaintiff for the class must file their papers with the court by June 3, 2024.
  • A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.

Hagens Berman Files New Securities Class Action Against Plug Power (Plug) And Its Senior Executives: New Complaint Extends Alleged Fraudulent Period From Mar. 1, 2023 – Jan. 16, 2024, Inclusive; Lead Plaintiff Filing Deadline Remains May 21, 2024

Retrieved on: 
måndag, maj 6, 2024
Action Replay, News, Morgan Stanley, Complaint, Extension, District court, Court, Plug Power, Plug, SAN, Alpha, Tobacco

The new complaint extends the alleged fraudulent period in the pending litigation against Plug Power, contending that Plug Power’s stock was artificially inflated by defendants’ alleged fraud from Mar.

Key Points: 
  • The new complaint extends the alleged fraudulent period in the pending litigation against Plug Power, contending that Plug Power’s stock was artificially inflated by defendants’ alleged fraud from Mar.
  • Lead plaintiff motions for the Plug Power class action litigation must still be filed with the Court no later than May 21, 2024.
  • Hagens Berman therefore urges investors who suffered substantial losses on purchases of Plug Power securities during the Extended Class Period and who wish to serve as lead plaintiff of the Plug Power litigation to contact Hagens Berman now .
  • A lead plaintiff acts on behalf of all other class members in directing the Plug Power class action lawsuit.

Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in Glasgow

Retrieved on: 
måndag, maj 6, 2024
Immortalised cell line, Congress, Mouse, Pancreatic cancer, Immunotherapy, Area studies, FDR, KPC, Alpha Sigma Tau, Patient, Neoplasm, Financial asset, Radiation therapy, Alpha, Medical imaging

JERUSALEM, May 06, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today the presentation of new preclinical data at the 2024 congress of the European Society for Radiotherapy and Oncology (ESTRO), currently taking place in Glasgow, UK, examining observed responses in distant untreated tumors, otherwise known as an abscopal effect, generated by Alpha DaRT in pancreatic cancer tumors in mice. The Company’s Chief Medical Officer, Dr. Robert Den, delivered a company presentation during the weekend entitled “Innovative Use of Radium-224 for Intralesional Treatment of Various Forms of Solid Tumors.” Among other things, the presentation included data from studies examining the use of Alpha DaRT to treat Panc02 and KPC pancreatic cancer tumor-bearing mice with multiple tumors.

Key Points: 
  • In these preclinical studies, mice were initially inoculated intracutaneously with the Panc02 or KPC murine cell lines, and then shortly thereafter were inoculated with a secondary tumor of the same cell line in a distant site.
  • The first tumor was treated with Alpha DaRT sources 9-10 days after inoculation, or with an inert source as a control, and the size of the secondary untreated tumor was measured every 3-4 days thereafter for 29 days.
  • The percent change in tumor volume over time was assessed and compared between the groups with Repeated Measures ANOVA models.
  • A similar pattern was also observed when examining the Panc02 and KPC tumor models individually rather than grouped in one larger analysis.